Targeting glycolysis with 2-deoxy-d-glucose sensitizes primary cell cultures of renal cell carcinoma to tyrosine kinase inhibitors
Adrian Georg Simon, Laura Esser, Jörg Ellinger, Vittorio Branchi, Yuri Tolkach, Stefan C. Müller, Manuel Ritter, Glen Kristiansen, Michael H. Muders, Thomas Mayr, Marieta Toma
Topics & Concepts
PazopanibCancer researchTyrosine-kinase inhibitorAxitinibTyrosine kinaseClear cell renal cell carcinomaGlycolysisRenal cell carcinomaBiologyAnaerobic glycolysisCancerMedicineCancer cellInternal medicineSunitinibEndocrinologyBiochemistrySignal transductionMetabolismRenal cell carcinoma treatmentCancer, Hypoxia, and MetabolismChemotherapy-induced organ toxicity mitigation